Guardion Health Sciences Inc
NASDAQ:GHSI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guardion Health Sciences Inc
Operating Income
Guardion Health Sciences Inc
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Guardion Health Sciences Inc
NASDAQ:GHSI
|
Operating Income
-$4.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Estee Lauder Companies Inc
NYSE:EL
|
Operating Income
$1.4B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-2%
|
|
|
Bellring Brands Inc
NYSE:BRBR
|
Operating Income
$320.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Coty Inc
NYSE:COTY
|
Operating Income
$545.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Operating Income
$270.3m
|
CAGR 3-Years
10%
|
CAGR 5-Years
31%
|
CAGR 10-Years
16%
|
|
|
elf Beauty Inc
NYSE:ELF
|
Operating Income
$168.3m
|
CAGR 3-Years
39%
|
CAGR 5-Years
69%
|
CAGR 10-Years
21%
|
|
Guardion Health Sciences Inc
Glance View
Guardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The company is headquartered in Houston, Texas and currently employs 13 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products and devices designed to support healthcare professionals and providers, and their patients and consumers. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplement chews for bone health, immune health, and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel-flavored calcium chews constitute the main product category. The company also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The firm's GlaucoCetin, a medical food, which offers a formula that is designed to support proper mitochondrial function in the optic nerve cells in glaucoma patients.
See Also
What is Guardion Health Sciences Inc's Operating Income?
Operating Income
-4.2m
USD
Based on the financial report for Jun 30, 2024, Guardion Health Sciences Inc's Operating Income amounts to -4.2m USD.
What is Guardion Health Sciences Inc's Operating Income growth rate?
Operating Income CAGR 5Y
8%
Over the last year, the Operating Income growth was 23%. The average annual Operating Income growth rates for Guardion Health Sciences Inc have been 26% over the past three years , 8% over the past five years .